U.S. Hospitals Are Running Out Of A Crucial Covid Drug Amid Delta Surge And Worldwide Shortages Hospitals could be without tocilizumab, one of the only therapies for Covid-19 patients cleared for use in the U.S., for weeks and the World Health Organization urged maker Roche to ensure it is distributed fairly around the world.